Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 11.03.2019 1 Aliment Pharmacol Ther 2 Am J Gastroenterol 1 Dig Dis Sci 4 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 3 Gastroenterology 1 Gut 1 Hum Pathol 5 Inflamm Bowel Dis 2 J Crohns Colitis 2 Lancet Gastroenterol Hepatol 1 PLoS Genet 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. JACKSON B, Begun J, Gray K, Churilov L, et al
   Clinical decision support improves quality of care in patients with ulcerative colitis.
   Aliment Pharmacol Ther. 2019 Mar 7. doi: 10.1111/apt.15209.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

2. BARNES EL, Kappelman MD, Long MD, Evon DM, et al
   A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.
   Am J Gastroenterol. 2019 Mar 1. doi: 10.14309/ajg.0000000000000177.
   PubMed     Text format     Abstract available
   
   
3. RUBIN DT, Ananthakrishnan AN, Siegel CA, Sauer BG, et al
   ACG Clinical Guideline: Ulcerative Colitis in Adults.
   Am J Gastroenterol. 2019;114:384-413.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis Sci

4. DAI C, Jiang M, Sun MJ
   High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis.
   Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05531.
   PubMed     Text format    
   
   

   
   Eur J Gastroenterol Hepatol

5. VERDEJO C, Hervias D, Roncero O, Arias A, et al
   Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
   Eur J Gastroenterol Hepatol. 2018;30:1521-1527.
   PubMed     Text format     Abstract available
   
   
6. BHOYRUL B, Hilmy M, Lyon C
   Crohn's disease of the penis and scrotum: a prospective study.
   Eur J Gastroenterol Hepatol. 2018;30:1528-1529.
   PubMed     Text format    
   
   
7. ARIEIRA C, Monteiro S, Xavier S, Dias de Castro F, et al
   Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference.
   Eur J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1097/MEG.0000000000001319.
   PubMed     Text format     Abstract available
   
   
8. MOENS A, Verstockt B, Machiels K, Bossuyt P, et al
   Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades.
   Eur J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1097/MEG.0000000000001394.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterol Hepatol

9. LOPEZ-SANROMAN A, Clofent J, Garcia-Planella E, Menchen L, et al
   Reviewing the therapeutic role of budesonide in Crohn's disease.
   Gastroenterol Hepatol. 2018;41:458-471.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterology

10. TSANG L, Banerjee N, Tabibian JH
    Not your typical inflammatory bowel disease flare: diarrhea and weight loss masquerading as recrudescence of ulcerative colitis.
    Gastroenterology. 2019 Mar 1. pii: S0016-5085(19)32503.
    PubMed     Text format    
    
    
11. GROSEN A, Bungum M, Hvas CL, Julsgaard M, et al
    Vedolizumab Does Not Impair Sperm DNA Integrity in Men With Inflammatory Bowel Disease.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32509.
    PubMed     Text format    
    
    
12. PARISINOS CA
    Reply.
    Gastroenterology. 2019;156:824.
    PubMed     Text format    
    
    

    
    Gut

13. ZUO T, Lu XJ, Zhang Y, Cheung CP, et al
    Gut mucosal virome alterations in ulcerative colitis.
    Gut. 2019 Mar 6. pii: gutjnl-2018-318131. doi: 10.1136/gutjnl-2018-318131.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

14. OSMOND A, Ashok D, Francoeur CA, Miller M, et al
    Is focal active colitis of greater clinical significance in pediatric patients? A retrospective review of 68 cases with clinical correlation.
    Hum Pathol. 2018;74:164-169.
    PubMed     Text format     Abstract available
    
    

    
    Inflamm Bowel Dis

15. MOULTON CD, Hopkins CWP, Mohamedali Z, Powell N, et al
    Out of Sight, Out of Mind: The Limitations of the Hospital Anxiety and Depression Scale in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2019 Mar 2. pii: 5368192. doi: 10.1093.
    PubMed     Text format    
    
    
16. TAFT TH, Bedell A, Craven MR, Guadagnoli L, et al
    Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2019 Mar 7. pii: 5370427. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
17. PETITO V, Fiore L, Lopetuso LR, Scaldaferri F, et al
    Commentary to "Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease".
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370426. doi: 10.1093.
    PubMed     Text format    
    
    
18. CHEN C, Hartzema AG, Xiao H, Wei YJ, et al
    Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5370024. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
19. DAO A, Abidian M, Lestrange A, Mattar M, et al
    Oral Vancomycin Induces and Maintains Remission of Ulcerative Colitis in the Subset of Patients With Associated Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2019 Mar 6. pii: 5369961. doi: 10.1093.
    PubMed     Text format    
    
    

    
    J Crohns Colitis

20. PHILIP G, Cornillie F, Adedokun JO, Melsheimer R, et al
    Early dose optimization of golimumab in nonresponders to induction treatment for ulcerative colitis is effective and supported by pharmacokinetic data.
    J Crohns Colitis. 2019 Mar 7. pii: 5371269. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
21. MORAN-LEV H, Galai T, Yerushalmy-Feler A, Weisman Y, et al
    Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Pediatric Patients- A Prospective Study.
    J Crohns Colitis. 2019 Mar 6. pii: 5370430. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

22. TAYLOR SA, Mallett S, Bhatnagar G, Baldwin-Cleland R, et al
    Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial.
    Lancet Gastroenterol Hepatol. 2018 Jun 15. pii: S2468-1253(18)30161.
    PubMed     Text format     Abstract available
    
    
23. GECSE KB
    Risankizumab: a game changer in Crohn's disease?
    Lancet Gastroenterol Hepatol. 2018;3:656-657.
    PubMed     Text format    
    
    

    
    PLoS Genet

24. ASCHARD H, Laville V, Tchetgen ET, Knights D, et al
    Genetic effects on the commensal microbiota in inflammatory bowel disease patients.
    PLoS Genet. 2019;15:e1008018.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. NISHIDA Y, Hosomi S, Yamagami H, Sugita N, et al
    Pretreatment neutrophil-to-lymphocyte ratio predicts clinical relapse of ulcerative colitis after tacrolimus induction.
    PLoS One. 2019;14:e0213505.
    PubMed     Text format     Abstract available
    
    
26. MAHALHAL A, Williams JM, Johnson S, Ellaby N, et al
    Oral iron exacerbates colitis and influences the intestinal microbiome.
    PLoS One. 2018;13:e0202460.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: